As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd has successfully completed an inspection by NAFDAC (Nigeria's food and drug regulator) on December 9, 2025. The audit covered quality systems, manufacturing practices, documentation, and compliance parameters. The company received a clean report with no critical observations. This is a positive regulatory outcome that supports the company's ability to continue supplying pharmaceutical products to the Nigerian market.
A clean NAFDAC audit is a key regulatory milestone for pharma exporters and reduces compliance risk for Norris's Nigeria business. For shareholders, this is a positive signal for uninterrupted exports, though no immediate financial impact or new revenue is indicated by the announcement itself.